Related Experiment Video
Updated: Aug 13, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Elevation of serum major basic protein in patients with atopic dermatitis
H Morita1, K Yamamoto, Y Kitano
1Department of Dermatology, Hyogo College of Medicine, Japan.
Journal of Dermatological Science
|May 1, 1995
Summary
Serum levels of major basic protein (MBP) are elevated in patients with atopic dermatitis (AD). Higher MBP levels correlate with increased disease severity, suggesting MBP as a potential biomarker for AD activity.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition.
- Identifying reliable biomarkers for AD disease activity is crucial for effective management.
Purpose of the Study:
- To investigate serum levels of major basic protein (MBP) in patients with atopic dermatitis.
- To assess the correlation between serum MBP levels and the clinical severity of AD.
Main Methods:
- Serum samples were collected from patients diagnosed with atopic dermatitis and healthy controls.
- MBP concentrations in serum were quantified using appropriate laboratory assays.
- Clinical severity of AD was evaluated using a standardized clinical scoring system.
Main Results:
- Patients with atopic dermatitis exhibited significantly higher serum MBP levels compared to normal controls.
- A significant positive correlation was observed between serum MBP levels and the clinical severity score in AD patients.
Conclusions:
- Serum MBP may serve as a valuable indicator of disease activity in atopic dermatitis.
- Elevated MBP levels reflect the inflammatory processes underlying AD and its severity.
